Neoadjuvant PD-1 Blockade Seems Effective in Glioblastoma

WEDNESDAY, Feb. 13, 2019 -- Neoadjuvant administration of programmed cell death protein 1 (PD-1) blockade seems to enhance local and systemic antitumor immune response in glioblastoma, according to a study published online Feb. 11 in Nature...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news